Impact helps build global biosimilar brands. Our programs accelerate biosimilar uptake and provide you with meaningful differentiation in an increasingly competitive market.
We understand the challenges facing new biosimilars and can advise you on how to maximize clinician engagement and long term adoption of your brand.
Our global programs have supported the most successful biosimilar launch to date.
Our insights shape our programs to help you:
Simplify communication about the biosimilar story, the regulatory and approval processes, and the concept of extrapolation
Incorporate peer-to-peer collaboration, allowing individuals to act as advocates to endorse the benefits of adopting biosimilars
Work with early adoptors to share how they have successfully introduced biosimilars, in naïve and/or ‘switch’ patients
Enable effective conversations between the clinician and the patient – critical for adopting biosimilars
Differentiate beyond price to help build your biosimilar brand
We analyze the challenges and opportunities facing your biosimilar brand in three critical areas:
Based on this analysis, we create and develop bespoke programs to help build your biosimilar brand.
We also recommend creative approaches to maintain engagement and commitment from your local operating companies. We know how critical this is to support the launch phase and drive effective execution for your biosimilar brand.
Although the first biosimilar was approved in 2006, it is only over the last few years that they have been attracting headlines.
This is largely due to two key factors:
These two factors bring biosimilars center stage and facilitate access to new innovative medicines as well as existing biologics.
However, the biosimilar market will become unsustainable if defined by price alone. Along with accelerating adoption, incorporating value-added services as part of building a biosimilar brand is a key priority for any company aiming to ‘win’ long-term.
Our senior team has over 30 years’ pharmaceutical marketing and medical education experience.
The senior team is supported by experienced program and editorial teams who are involved in the day-to-day delivery of our brand building programs.
If you are building a biosimilar brand and would like to benefit from our insights please email or call to find out how we can help.